Top Stories Atossa Genetics Receives Mixed Analyst Ratings and Price Target Atossa Genetics Inc. (NASDAQ:ATOS) has garnered a consensus recommendation of “Hold” from five brokerages monitoring the company, according to Marketbeat.com. The analysis reveals a... Editorial1 January, 2026